The goal of AMOR-X is to develop an entirely off pump, minimally invasive implantable aortic valve to implant into patients with indication to aortic valve replacement due to high grade aortic valve stenosis. The vision of AMOR-X is to reduce significantly not only the procedure related mortality, but also the procedure related morbidity, enhancing patient quality of life.
The Autovalve™ technology will become the standard in stenosed aortic valve replacement.

AMOR-X has, in collaboration with CMI, developed a novel and unique way to perform an off-pump, small access aortic valve replacement. The stenosed Aortic Valve will thereby be left in place.

The proprietary Autovalveâ„¢ system contains the following components:
• Off-pump ventricular access device
• Ventricular fixation system
• Valved conduit
• Aortic anastomotic device